Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients
Recruiting
Observational Study
Heart Injuries
Anthracycline
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 – 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 22 (estimated)
- Sponsor
- IRCCS Burlo Garofolo · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study investigates the role of echocardiography and of serum biomarkers (NT-proBNP, cardiac Troponin-I) in predicting cardiac injury in a cohort of paediatric oncological patients treated with Anthracycline chemotherapy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Paediatric oncological patients 0-18 years
* Planned start of anthracycline therapy
* Normal left ventricular systolic function according to International Guidelines before the treatment with AC
Exclusion Criteria:
* Previous anthracycline treatment, bone marrow transplantat…
Contacts